贵州三力: 贵州三力制药股份有限公司关于部分高级管理人员减持计划实施完毕暨减持结果公告

Summary of Key Points Core Viewpoint - The announcement details the completion of share reduction plans by two senior executives of Guizhou Sanli Pharmaceutical Co., Ltd, highlighting the specific amounts and percentages of shares sold, as well as the financial implications of these transactions. Group 1: Shareholding Information - Before the reduction, Vice General Manager Yu Yuan held 325,000 shares, accounting for 0.0793% of the total share capital, while Vice General Manager Luo Zhanbiao held 370,000 shares, representing 0.0903% of the total share capital [1][2]. Group 2: Reduction Plan Implementation Results - The reduction plan was first disclosed on June 12, 2025, with Yu Yuan planning to reduce his holdings by up to 45,000 shares and Luo Zhanbiao by up to 60,000 shares [1][2]. - As of July 9, 2025, Yu Yuan successfully reduced his holdings by 45,000 shares, which is 0.0110% of the total share capital, while Luo Zhanbiao reduced his holdings by 60,000 shares, accounting for 0.0146% of the total share capital [1][3]. - The share prices during the reduction were in the range of 11.92 CNY per share for Yu Yuan and between 11.90 to 11.91 CNY per share for Luo Zhanbiao, with total amounts of 536,053.81 CNY and 713,838.99 CNY respectively [2][3].